Identification of southern Taiwan genetic variants in thyroid dyshormonogenesis through whole‐exome sequencing
The Kaohsiung Journal of Medical Sciences · 2024
DOI: 10.1002/kjm2.12871 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2024. Verfasst von Ching-Chao Tsai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Exome Sequencing, Congenital Hypothyroidism, Iodide Peroxidase, Receptors, Thyrotropin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cheng Kung University Hospital.
Abstract (Originalsprache)
Thyroid dyshormonogenesis (TDH) is responsible for 15%–25% of congenital hypothyroidism (CH) cases. Pathogenetic variants of this common inherited endocrine disorders vary geographically. Unraveling the genetic underpinnings of TDH is essential for genetic counseling and precise therapeutic strategies. This study aims to identify genetic variants associated with TDH in Southern Taiwan using whole exome sequencing (WES). We included CH patients diagnosed through newborn screening at a tertiary medical center from 2011 to 2022. Permanent TDH was determined based on imaging evidence of bilateral thyroid structure and the requirement for continuous medication beyond 3 years of age. Genomic DNA extracted from blood was used for exome library construction, and pathogenic variants were detected using an in‐house algorithm. Of the 876 CH patients reviewed, 121 were classified as permanent, with 47 (40%) confirmed as TDH. WES was conducted for 45 patients, and causative variants were identified in 32 patients (71.1%), including DUOX2 (15 cases), TG (8 cases), TSHR (7 cases), TPO (5 cases), and DUOXA2 (1 case). Recurrent variants included DUOX2 c.3329G>A, TSHR c.1349G>A, TG c.1348delT, and TPO c.2268dupT. We identified four novel variants based on genotype, including TSHR c.1135C>T, TSHR c.1349G>C, TG c.2461delA, and TG c.2459T>A. This study underscores the efficacy of WES in providing definitive molecular diagnoses for TDH. Molecular diagnoses are instrumental in genetic counseling, formulating treatment, and developing management strategies. Future research integrating larger population cohorts is vital to further elucidate the genetic landscape of TDH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Genomic Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Pediatrics, Kuo General Hospital, Tainan, Taiwan.
- Department of Medical Humanities and Social Medicine, School of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
ORCID-Profile: Ching-Chao Tsai, Yu-Wen Pan
Förderung
- National Cheng Kung University Hospital
Zitieren
APA
Tsai, C. C., Chang, Y. M., Chou, Y. Y., Chen, S. Y., Pan, Y. W., & Tsai, M. C. (2024). Identification of southern Taiwan genetic variants in thyroid dyshormonogenesis through whole‐exome sequencing. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12871
Vancouver
Tsai CC, Chang YM, Chou YY, Chen SY, Pan YW, Tsai MC. Identification of southern Taiwan genetic variants in thyroid dyshormonogenesis through whole‐exome sequencing. The Kaohsiung Journal of Medical Sciences. 2024. doi:10.1002/kjm2.12871
BibTeX
@article{Tsai2024,
author = {Tsai, Ching-Chao and Chang, Yu-Ming and Chou, Yen-Yin and Chen, Shou-Yen and Pan, Yu-Wen and Tsai, Meng-Che},
title = {Identification of southern Taiwan genetic variants in thyroid dyshormonogenesis through whole‐exome sequencing},
journal = {The Kaohsiung Journal of Medical Sciences},
year = {2024},
doi = {10.1002/kjm2.12871}
}
EUVIMED